India's #1 Financial News | Nifty 50 Live, Sensex Today, Bitcoin Price INR, Gold Rate, Stock Market & Crypto Analysis by Expert Team
India's #1 Financial News | Nifty 50 Live, Sensex Today, Bitcoin Price INR, Gold Rate, Stock Market & Crypto Analysis by Expert Team
GOLDMAN SACHS ON NEULAND LABS
• Reiterate Buy, target price 12,975 from Rs 11,400
• FDA approval for Cobenfy is a key event
• FY26 Xanomile estimates to be up 55-60%
• CDMO business multiple raised to 40x from 37x GOLDMAN SACHS ON NEULAND LABS
• Reiterate Buy, target price 12,975 from Rs 11,400
• FDA approval for Cobenfy is a key event
• FY26 Xanomile estimates to be up 55-60%
• CDMO business multiple raised to 40x from 37x
No related posts.
Raj Gaurav Rai is the founder and chief editor of EarnFree.in with 10+ years of experience in Indian equity markets, technical analysis, Nifty 50, Bank Nifty F&O trading, cryptocurrency and financial journalism. He actively trades NSE/BSE equities and crypto markets, ensuring all analysis is grounded in real market experience. Based in Varanasi, Uttar Pradesh, India.
